Measurement of corneal aberrations for customisation of intraocular lens asphericity: impact on quality of vision after micro-incision cataract surgery
- Correspondence to Dr Nochez Yannick, Department of Ophthalmology, University Hospital of Tours, 2 boulevard Tonnellé, Tours F-37000, France; yannick.nochez{at}free.fr
- Accepted 27 August 2009
- Published Online First 14 October 2009
Abstract
Aims To compare the quality of vision of patients with customised aspheric intraocular lenses (IOL) versus patients implanted with zero-aberration IOL after a 1.8 mm micro-incision cataract surgery (MICS).
Methods Fourty-three eyes were divided into two groups: 17 eyes (reference group) received zero aberration Acri.Smart 46LC and 26 eyes received a customised-aspheric IOL: either aspherical Acri.Smart 36A, generating a −0.18 μm SA compensation equivalent, or zero-aberration Acri.Smart 46LC. IOL asphericity was individually selected according to the corneal spherical aberration (SA) in order to produce a residual ocular SA close to +0.10 μm. Refraction, best-corrected visual acuity (BCVA), contrast sensitivities, ocular wavefront aberrations and objective quality of vision assessment were analysed 6 months after MICS.
Results Postoperative BCVA was similar in both groups (p=0.58). Mesopic contrast sensitivities were significantly better in the custom group at intermediate and high spatial frequencies (p<0.001), while photopic contrast sensitivities were similar. Total SA was significantly lower in the custom group (Z40=0.085±0.075 vs 0.261±0.091 μm, p<0.001), whereas no difference was found in preoperative corneal SA. Modulation transfer function cut-off frequency was higher in the custom group than in the reference group (34.3±8.1 vs 23.57±8.6 cycles per degree, respectively; p=0.008).
Conclusion Individual selection of IOL asphericity with a preoperative corneal SA measurement allowed control of final ocular SA. Such customisation improves mesopic contrast sensitivity, and leads to better objective quality of vision.
- Cataract
- clinical trial, cornea
- contrast sensitivity
- customised aspheric IOL
- imaging
- optics and refraction
- quality of vision
- wavefront aberrations
Footnotes
-
Competing interests None.
-
Ethics approval This study was conducted with the approval of the local ethics committee (CHU Bretonneau).
-
Patient consent Obtained.
-
Provenance and peer review Not commissioned; externally peer reviewed.









